Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
4,527,832
-
Total 13F shares
-
749,870
-
Share change
-
+567,547
-
Total reported value
-
$1,532,176
-
Price per share
-
$2.11
-
Number of holders
-
11
-
Value change
-
+$1,147,474
-
Number of buys
-
10
Institutional Holders of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) as of Q4 2024
As of 31 Dec 2024,
PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
749,870 shares.
The largest 10 holders included
Hudson Bay Capital Management LP, Harraden Circle Investments, LLC, Essential Planning, LLC., AdvisorShares Investments LLC, HRT FINANCIAL LP, UBS Group AG, Virtu Financial LLC, CITADEL ADVISORS LLC, Scientech Research LLC, and Connective Capital Management, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.